Studying at the University of Verona

Study Plan

A.A. 2024/2025 A.A. 2023/2024 A.A. 2022/2023 A.A. 2021/2022 A.A. 2020/2021 A.A. 2019/2020 A.A. 2018/2019 A.A. 2017/2018 A.A. 2016/2017 A.A. 2015/2016 A.A. 2014/2015 A.A. 2013/2014 A.A. 2012/2013 A.A. 2011/2012 A.A. 2010/2011 A.A. 2009/2010

This information is intended exclusively for students already enrolled in this course.
If you are a new student interested in enrolling, you can find information about the course of study on the course page:

Laurea magistrale a ciclo unico in Medicina e chirurgia - Enrollment from 2025/2026

The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.

1° Year

ModulesCreditsTAFSSD
7
A
BIO/16
6
A
BIO/13
15
A
BIO/10
10
A/B
FIS/07 ,MED/01
3
E
L-LIN/12
9
B
BIO/17
2
D
-

2° Year  activated in the A.Y. 2017/2018

ModulesCreditsTAFSSD
11
A
BIO/16
15
A/B
BIO/11 ,BIO/13 ,MED/03
9
B
MED/04
9
B
MED/07
7
B/F
- ,M-PSI/08 ,SPS/07
2
D
-

3° Year  activated in the A.Y. 2018/2019

ModulesCreditsTAFSSD
5
B
MED/08
10
A/C
BIO/09
12
A
BIO/09 ,M-PSI/01
5
B/C/F
- ,BIO/12
19
B
MED/04 ,MED/09
2
D
-

4° Year  activated in the A.Y. 2019/2020

ModulesCreditsTAFSSD
6
B
MED/28 ,MED/30 ,MED/31
9
B/C
BIO/14
10
B/F
- ,MED/09 ,MED/18
22
B/F
- ,MED/08 ,MED/12 ,MED/15 ,MED/16 ,MED/17 ,MED/35
17
B/F
- ,MED/08 ,MED/10 ,MED/11 ,MED/13 ,MED/14 ,MED/21 ,MED/22 ,MED/23
1
D
-

5° Year  activated in the A.Y. 2020/2021

ModulesCreditsTAFSSD
5
B
MED/08
6
B
MED/06 ,MED/18
9
B/F
- ,MED/40
6
B
MED/36
3
B
MED/33
11
B/C/F
- ,MED/09
7
B
MED/26 ,MED/27 ,MED/34
6
B
MED/25
12
B/F
- ,MED/20 ,MED/38 ,MED/39
9
B
MED/42 ,MED/43 ,MED/44
1
D
-

6° Year  activated in the A.Y. 2021/2022

ModulesCreditsTAFSSD
13
B/F
- ,MED/09 ,MED/45
9
B
MED/09 ,MED/18 ,MED/41
6
B/F
- ,MED/18 ,MED/24
6
F
NN
8
F
NN
5
F
NN
Prova finale
15
E
-
activated in the A.Y. 2017/2018
ModulesCreditsTAFSSD
11
A
BIO/16
15
A/B
BIO/11 ,BIO/13 ,MED/03
9
B
MED/04
9
B
MED/07
7
B/F
- ,M-PSI/08 ,SPS/07
2
D
-
activated in the A.Y. 2018/2019
ModulesCreditsTAFSSD
5
B
MED/08
10
A/C
BIO/09
12
A
BIO/09 ,M-PSI/01
5
B/C/F
- ,BIO/12
19
B
MED/04 ,MED/09
2
D
-
activated in the A.Y. 2019/2020
ModulesCreditsTAFSSD
6
B
MED/28 ,MED/30 ,MED/31
9
B/C
BIO/14
10
B/F
- ,MED/09 ,MED/18
22
B/F
- ,MED/08 ,MED/12 ,MED/15 ,MED/16 ,MED/17 ,MED/35
17
B/F
- ,MED/08 ,MED/10 ,MED/11 ,MED/13 ,MED/14 ,MED/21 ,MED/22 ,MED/23
1
D
-
activated in the A.Y. 2020/2021
ModulesCreditsTAFSSD
5
B
MED/08
6
B
MED/06 ,MED/18
9
B/F
- ,MED/40
6
B
MED/36
3
B
MED/33
11
B/C/F
- ,MED/09
7
B
MED/26 ,MED/27 ,MED/34
6
B
MED/25
12
B/F
- ,MED/20 ,MED/38 ,MED/39
9
B
MED/42 ,MED/43 ,MED/44
1
D
-

Legend | Type of training activity (TTA)

TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.

A Basic activities
B Characterizing activities
C Related or complementary activities
D Activities to be chosen by the student
E Final examination
F Other training activities
S Placements in companies, public or private institutions and professional associations

Pharmacology - FARMACOVIGILANZA  (2019/2020)

Teaching code

4S01147

Teacher

Roberto Leone

Credits

1

Language

Italian

Scientific Disciplinary Sector (SSD)

BIO/14 - PHARMACOLOGY

Period

1° semestre dal Sep 30, 2019 al Jan 10, 2020.

Location

VERONA

Lessons timetable MoodleMoodle Seminars 0

To show the organization of the course that includes this module, follow this link:  Course organization

Learning outcomes

At the end of the Pharmacovigilance module, the student must have achieved the following objectives:
Understand the etiopathogenetic mechanisms of adverse drug reactions
Understand the international classification of adverse drug reactions
Know the main epidemiological data on adverse drug reactions
Know the most important methods for the study of drug safety
Know to fill out a report of adverse drug reaction

Program

WHO and EMA definitions of Adverse Drug Reaction (ADR)
International Classification of ADRs: Types A, B, C, D, E, F
Serious and non-serious adverse reactions: distinctive criteria; specific and non-specific ADRs
Epidemiology of ADRs; data on morbidity and mortality
Pathogenetic mechanisms of ADRs: dose-dependent and -independent; allergic reactions; pharmacogenetic reactions; teratogenicity; carcinogenesis
Drugs in pregnancy and breastfeeding
Pediatric adverse drug reactions
Adverse drug reactions in the elderly patients
Drug-drug interactions as cause of ADR
Economic impact of ADRs
Pharmacovigilance definition and history
The reasons and objectives of Pharmacovigilance
Main methodologies for the study of drug tolerability
The Italian ADRs reporting system
Italian and European pharmacovigilance legislation
The Italian reporting card: criteria for compilation
The Vigifarmaco Platform (on-line reporting)
ADR reporting by citizens
Web Searching and Big-Data

Reference texts
Author Title Publishing house Year ISBN Notes
F. Rossi, V. Cuomo, C. Riccardi Farmacologia (Edizione 3) Minerva Medica 2017 978-88-7711-881-3
Caputi, De Ponti, Pagliaro Reazioni avverse a farmaci Cortina Editore 2009 978-88-6030-278-6

Examination Methods

The knowledge of Pharmacovigilance will be assessed during the Pharmacology oral examination

Students with disabilities or specific learning disorders (SLD), who intend to request the adaptation of the exam, must follow the instructions given HERE